Atlas Trials

An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy

Clinical trial NCT03279263 · UNKNOWN

Trial details

NCT number
NCT03279263
Sponsor
Melior Pharmaceuticals
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2017-09-01
Primary completion
2019-09-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.